Skip to main content
. 2020 Jun 4;15:1261–1268. doi: 10.2147/COPD.S242191

Table 3.

Correlations (Robust Linear Model) Between Clinical Data and IAD Change After Aerobika® Treatment

r2 p
∆IAD (%) in UL ∆FEV1 (L) −0.50 0.032
∆PEF (L/s) −0.29 0.007
∆IAD (%) in LL ∆FEV1 (L) 0.50 0.032
∆PEF (L/s) 0.29 0.007

Abbreviations: IAD, internal airflow distribution; FRC, functional residual capacity; TLC, total lung capacity; UL, upper lobes; LL, lower lobes; FEV1, forced expiratory volume in one second; PEF, peak expiratory flow.